Florida Reports First Dengue Fever Death as Local Cases Surge

The Florida Department of Health has confirmed the state’s first death from dengue fever in 2026, coinciding with a notable increase in locally transmitted infections. Officials declined to release specific demographic details about the deceased, though the Tampa Bay Times initially reported that an 80-year-old woman from Tampa passed away on September 4.

State data indicates that 152 locally acquired dengue cases were confirmed for the week ending September 12. This figure represents the highest weekly tally recorded since 2023, when a total of 189 local cases were identified throughout the entire year, according to Centers for Disease Control and Prevention records.

Hillsborough County, which encompasses Tampa, has accounted for the majority of infections with 134 cases. Additional confirmed cases have been reported in Miami-Dade, Orange, Palm Beach, Pasco, and Pinellas counties.

Dengue is a mosquito-borne illness transmitted by Aedes species, which are prevalent in tropical and subtropical environments and also vectorize Zika and chikungunya viruses. There are four distinct strains of the dengue virus, and individuals can be infected multiple times over their lifetime.

According to the CDC, approximately one in four people who contract the virus will exhibit symptoms such as fever, rash, nausea, vomiting, and severe muscle or joint pain. These symptoms typically persist for two to seven days. In roughly one out of every 20 cases, the illness progresses to severe dengue, which can cause shock, internal bleeding, and fatality.

There are no antiviral treatments specific to dengue. Medical guidance recommends rest, hydration, and over-the-counter pain relievers, but patients are explicitly warned against using aspirin or ibuprofen due to the risk of stomach lining inflammation and bleeding. Severe cases often require hospitalization for intravenous fluid support.

Currently, no dengue vaccine is widely available in the United States. Although the FDA approved a vaccine in 2021 for children aged 9 to 16 with prior confirmed infections in endemic areas, the product has since been discontinued.

Health authorities advise prevention measures including the use of insect repellent, wearing long sleeves and pants, staying in air-conditioned environments, and eliminating standing water around homes to disrupt mosquito breeding cycles.